Finance entity

Gaudium IVF and Women Health

Company

All 1 tracked stories fall under one category: ipo. Gaudium IVF and Women Health is most often covered alongside Gaudium IVF, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.2 in the same window.

Last mentioned: Feb 24, 2026

Entity pulse

Recent coverage · Gaudium IVF and Women Health

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Gaudium IVF and Women Health

All 1 tracked stories fall under one category: ipo. Gaudium IVF and Women Health is most often covered alongside Gaudium IVF, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. We currently track 1 Finance story that mention Gaudium IVF and Women Health, all published on February 24, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 85 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Gaudium IVF and Women Health. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Tentative Listing

    Expected date for the shares to begin trading on the NSE and BSE.

  2. Allotment Finalization

    The basis of allotment is expected to be finalized for investors.

  3. Final Bidding Day

    The window for all investor categories to place bids closes.

  4. Day 2 Close

    Subscription reaches 3x with strong retail participation.

  5. IPO Opens

    Gaudium IVF opens its initial public offering for subscription.

Stories mentioning Gaudium IVF and Women Health 1

IPOs & Listings Neutral

Gaudium IVF IPO Enters Final Day with 3x Subscription and Steady GMP

Gaudium IVF and Women Health's initial public offering has entered its final day of bidding with a 3.00x subscription rate and a 6.33% grey market premium. The issue has seen particularly strong interest from retail and non-institutional investors as the company seeks to expand its footprint in India's growing fertility market.

2 sources

Gaudium IVF and Women Health is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.